NCT01958008 - BI 113608 Administered as Tablets Twice Daily Over 4 Weeks in Patients With Chronic Obstructive Pulmonary Disease Associated With Chronic Bronchitis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

Placebo to BI 113608 high dose b.i.d.

Film-coated tablet

DRUG

Placebo to BI 113608 low dose b.i.d.

Film-coated tablet

DRUG

BI 113608 high dose b.i.d.

Film-coated tablet

DRUG

Placebo to BI 113608 medium dose b.i.d.

Film-coated tablet

DRUG

BI 113608 low dose b.i.d.

Film-coated tablet

DRUG

BI 113608 medium dose b.i.d.

Film-coated tablet

Trial Locations (6)

Boehringer Ingelheim Investigational Site, Berlin

Boehringer Ingelheim Investigational Site, Frankfurt

Boehringer Ingelheim Investigational Site, Gauting

Boehringer Ingelheim Investigational Site, Großhansdorf

Boehringer Ingelheim Investigational Site, Lübeck

Boehringer Ingelheim Investigational Site, Mannheim